Both NURE and XLRE offer investors access to U.S. real estate investment trusts (REITs), but they represent fundamentally different strategies rather than direct competitors. This ETF comparison matters now because the real estate sector is navigating a shifting interest-rate landscape, evolving post-pandemic demand patterns, and a powerful capital cycle into data centers and healthcare properties. XLRE provides broad, low-cost exposure to the sector's largest and most liquid names, while NURE pursues a niche thesis that shorter lease durations can reprice rents faster than longer-term leases. Understanding their relative positioning helps investors choose the right tool for distinct goals.
NURE seeks to track the Dow Jones U.S. Select Short-Term REIT Index, a subset of REITs concentrated in apartment buildings, hotels, self-storage facilities, and manufactured home properties. The index targets REITs whose shorter lease durations allow rents to adjust more rapidly to market conditions. The fund typically holds around 30 securities and is passively managed, with holdings weighted by float-adjusted market capitalization and capped near 5% per issuer. The index is rebalanced quarterly.
Top holdings include HST, EXR, ESS, PSA, SUI, RHP, CUBE, ELS, UDR, and AMH. Its expense ratio is approximately 0.35%, and it launched in December 2016. As a smaller, more specialized vehicle, it offers focused sector exposure but with comparatively modest assets under management (AUM) and thinner trading liquidity.
XLRE seeks to track the Real Estate Select Sector Index, a market-capitalization-weighted benchmark of REITs and real estate companies drawn from the S&P 500, excluding mortgage REITs. The fund is passively managed, non-diversified, and rebalanced quarterly. It typically holds about 30 to 34 securities, dominated by large-cap names that anchor the U.S. listed real estate market.
Top holdings include WELL, PLD, EQIX, AMT, DLR, SPG, PSA, CBRE, O, and VTR. The top 10 holdings account for roughly 60% of assets, reflecting a concentrated large-cap tilt. With an expense ratio of just 0.08%, substantial AUM, and deep daily volume, XLRE is among the most cost-efficient and liquid ways to gain diversified U.S. real estate exposure.
The real estate sector is being reshaped by two opposing forces. On one side, elevated financing costs and persistent uncertainty around the path of interest rates have weighed on property valuations and compressed leverage-sensitive segments. On the other, secular demand for digital infrastructure — data centers, cell towers, and fiber — and for senior and healthcare housing has driven strong earnings growth among the sector's largest names, precisely the companies that dominate XLRE.
NURE's apartment, hotel, and self-storage operators sit closer to the consumer and travel cycle. Their shorter leases allow faster rent repricing, which can be advantageous when inflation is elevated but can also expose the fund to weaker occupancy and rate compression when demand cools. Regulatory and housing-supply dynamics further influence these subsectors, creating a distinct risk-and-return profile from the technology-adjacent growth concentrated in XLRE.
In recent weeks and market cycles, the relative positioning of these two funds has diverged meaningfully. XLRE has benefited from sector rotation into large-cap, growth-oriented real estate, particularly data centers and towers tied to artificial intelligence (AI) infrastructure spending, as well as healthcare REITs riding favorable demographic trends. Its concentration in mega-cap holdings has amplified exposure to these winners.
NURE, by contrast, has been more tethered to consumer, travel, and housing fundamentals. Its smaller asset base and narrower subsector focus tend to produce higher relative volatility and wider trading spreads, while its dividend yield has historically run slightly above the broader sector average. Overall, XLRE offers broader diversification and smoother trend consistency, whereas NURE delivers a more targeted, rate-sensitive thematic bet.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending names, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to streamline your own research workflow.
Based on observable structural factors, Tickeron's AI would likely favor XLRE over NURE in the current environment. XLRE combines a materially lower expense ratio, dramatically greater liquidity, broader diversification across growth-oriented subsectors, and stronger trend consistency driven by data-center, tower, and healthcare demand. While NURE offers a defensible thematic niche in short-term-lease properties, its higher cost, thinner liquidity, and narrower exposure elevate relative risk. On balance, the AI would assign a higher probability of favorable risk-adjusted positioning to XLRE.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
XLRE moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 51 of 55 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for XLRE crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.
Following a +3.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLRE advanced for three days, in 253 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 218 of 275 cases where XLRE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for XLRE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 26 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLRE as a result. In 67 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for XLRE turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 42 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
The 50-day moving average for XLRE moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
XLRE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| NURE | XLRE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 82% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 80% |
| Advances ODDS (%) | 4 days ago 80% | 16 days ago 83% |
| Declines ODDS (%) | 8 days ago 84% | 3 days ago 83% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 79% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, XLRE has been closely correlated with EXR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLRE jumps, then EXR could also see price increases.
| Ticker / NAME | Correlation To XLRE | 1D Price Change % | ||
|---|---|---|---|---|
| XLRE | 100% | +0.07% | ||
| EXR - XLRE | 76% Closely correlated | +0.31% | ||
| PSA - XLRE | 73% Closely correlated | +0.25% | ||
| KIM - XLRE | 73% Closely correlated | +0.23% | ||
| O - XLRE | 72% Closely correlated | +0.41% | ||
| SPG - XLRE | 71% Closely correlated | +0.50% | ||
More | ||||